Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-05
2005-04-05
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S568000, C546S301000, C562S426000
Reexamination Certificate
active
06875780
ABSTRACT:
This invention relates to compounds that alter PPAR activity. The invention also relates to pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing dyslipidemia, hypercholesterolemia, obesity, hyperglycemia, atherosclerosis, hypertriglyceridemia and hyperinsulinemia in a mammal. The present invention also relates to methods for making the disclosed compounds.
REFERENCES:
patent: 5447656 (1995-09-01), Jungbauer et al.
patent: 6506757 (2003-01-01), Tajima et al.
patent: 20030207915 (2003-11-01), Cheng et al.
patent: 20030207916 (2003-11-01), Cheng et al.
patent: 20030207924 (2003-11-01), Cheng et al.
patent: 3526235 (1986-05-01), None
patent: 4002374 (1991-08-01), None
patent: 0578054 (1994-01-01), None
patent: 0625513 (1994-11-01), None
patent: 0930299 (1999-07-01), None
patent: 09194418 (1997-07-01), None
patent: WO9604228 (1996-02-01), None
patent: WO9728137 (1997-08-01), None
patent: WO 9728149 (1997-08-01), None
patent: WO9946232 (1999-09-01), None
patent: WO 0100603 (2001-01-01), None
patent: WO 0116120 (2001-03-01), None
patent: WO0250048 (2002-06-01), None
patent: WO02062774 (2002-08-01), None
patent: WO 02092590 (2002-11-01), None
patent: WO 02100403 (2002-12-01), None
patent: WO 03024395 (2003-03-01), None
Qian et al, Chemical Communications, vol. 22, pp. 2312-2313, 2001.*
T. Gordon et al., The American Journal of Medicine, 1977;62:707-714.
Rissanen et al., British Medical Journal,301:835-837 (1990).
W.R. Oliver et al., PNAS, vol. 98, pp. 5306-5311, (2001).
S.M. Berge et al., “Pharmaceutical Salts”, Journal of Pharmaceutical Sciences, 1977;66:1-19.
Belleney, J. et al., J. Heterocyclic Chem., 1984;21:1431.
Nishimura, Koji: “Preparation of Indole Derivatives as Chymase Inhibitors and Drugs containing the same as the active Ingredient” XP002258311.
Nanteuil De G et al: “5-Imidaol-1-yl-1H-Benzimidazoles Inhibiteurs De L Interleukine-1: UNE Nouvelle Voie Pour Le Traitement De L' Arthrose” XP001147539.
Auerbach Bruce J.
Bratton Larry D.
Filzen Gary F.
Geyer Andrew G.
Trivedi Bharat K.
Davis Zinna Northington
Leon Andrew J.
Sherwood Michelle A.
Warner-Lambert & Company
LandOfFree
Compounds that modulate PPAR activity and methods for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds that modulate PPAR activity and methods for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that modulate PPAR activity and methods for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3412897